Anan Futoshi, Masaki Takayuki, Iwao Tetsu, Eto Takeshi, Shimomura Tsuyoshi, Umeno Yoshikazu, Eshima Nobuoki, Saikawa Tetsunori, Yoshimatsu Hironobu
Department of Cardiology, Oita Red Cross Hospital, Oita, Japan.
Curr Med Res Opin. 2008 Jun;24(6):1561-7. doi: 10.1185/03007990802061818. Epub 2008 Apr 17.
The presence of white matter lesions (WML) is an important prognostic factor for the development of stroke. Microalbuminuria, which is associated with diabetes, has been flagged as a novel predictor for cerebrovascular events. This preliminary study was therefore designed to test the hypothesis that the presence of WML correlates with microalbuminuria and insulin resistance in patients with type 2 diabetic mellitus (DM) not receiving insulin treatment.
Based on brain magnetic resonance imaging (MRI) findings, 90 type 2 diabetic patients were divided into two groups: a WML-positive group (57+/-8 years, mean+/-SD, n=34) and a WML-negative group (57+/-6 years, n=56). The level of blood glucose was assessed by fasting plasma glucose (FPG), fasting immunoreactive insulin (F-IRI), homeostasis model assessment (HOMA) index, and hemoglobin A(1c) (HbA1c).
The body mass index was higher in the WML-positive group than in the WML-negative group (p<0.01). Plasma levels of triglycerides were higher while high-density lipoprotein cholesterol (HDL-C) was lower in the WML-positive group than in the WML-negative group (p<0.05 and p<0.0001, respectively). Fasting plasma glucose (p<0.005), insulin concentrations (p<0.0001), HOMA index (p<0.0001), and urinary albumin excretion (p<0.0001) levels were higher in the WML-positive group than in the WML-negative group. Multivariate logistic analysis revealed that WML was independently predicted by the microalbuminuria and insulin resistance (p<0.005, p<0.0005, respectively).
The results of this preliminary study indicate that the presence of WML was associated with the microalbuminuria and insulin resistance in these Japanese patients with type 2 DM; larger cohort studies are warranted to confirm these findings.
脑白质病变(WML)的存在是中风发生的一个重要预后因素。与糖尿病相关的微量白蛋白尿已被视为脑血管事件的一个新的预测指标。因此,本初步研究旨在检验以下假设:在未接受胰岛素治疗的2型糖尿病(DM)患者中,WML的存在与微量白蛋白尿和胰岛素抵抗相关。
根据脑磁共振成像(MRI)结果,将90例2型糖尿病患者分为两组:WML阳性组(年龄57±8岁,平均±标准差,n = 34)和WML阴性组(年龄57±6岁,n = 56)。通过空腹血糖(FPG)、空腹免疫反应性胰岛素(F-IRI)、稳态模型评估(HOMA)指数和糖化血红蛋白A1c(HbA1c)评估血糖水平。
WML阳性组的体重指数高于WML阴性组(p<0.01)。WML阳性组的血浆甘油三酯水平较高,而高密度脂蛋白胆固醇(HDL-C)水平低于WML阴性组(分别为p<0.05和p<0.0001)。WML阳性组的空腹血糖(p<0.005)、胰岛素浓度(p<0.0001)、HOMA指数(p<0.0001)和尿白蛋白排泄水平(p<0.0001)均高于WML阴性组。多因素逻辑分析显示,微量白蛋白尿和胰岛素抵抗可独立预测WML(分别为p<0.005,p<0.0005)。
本初步研究结果表明,在这些日本2型糖尿病患者中,WML的存在与微量白蛋白尿和胰岛素抵抗相关;需要更大规模的队列研究来证实这些发现。